Korean J Urol.  2013 Feb;54(2):73-77.

Chlamydia and Male Lower Urinary Tract Diseases

• Lee YS
• Lee KS

Abstract

Of the chlamydia species that can cause infections in humans, C. trachomatis is responsible for lower urinary tract diseases in men and women. C. trachomatis infections are prevalent worldwide, but current research is focused on females, with the burden of disease and infertility sequelae considered to be a predominantly female problem. However, a role for this pathogen in the development of male urethritis, epididymitis, and orchitis is widely accepted. Also, it can cause complications such as chronic prostatitis and infertility. This review summarizes C. trachomatis infection in the male genitourinary tract, including urethritis, epididymitis, orchitis, and its complications, and addresses the microbiology, epidemiology, screening, clinical manifestations, diagnosis, and treatment.

Keyword

Chlamydia; Chronic prostatitis; Epididymitis; Infertility orchitis; Urethritis

MeSH Terms

Chlamydia
Epididymitis
Female
Humans
Infertility
Male
Mass Screening
Orchitis
Prostatitis
Urethritis
Urinary Tract
Urologic Diseases

Reference

1. Halberstadter L, von Prowazek S. Uber Zelleinschlusse parasitarer Natur beim Trachom. Arb Gesundh (Berlin). 1907. 26:44–47.

2. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. 2001. Geneva: World Health Organization.

3. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2009. 2010. Atlanta: Centers for Disease Control and Prevention.

4. Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, et al. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess. 2007. 11:iii–iv. ix–xii. 1–165.

5. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. 2004. 291:2229–2236.

6. van Bergen J, Gotz HM, Richardus JH, Hoebe CJ, Broer J, Coenen AJ, et al. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect. 2005. 81:17–23.

7. Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S, Wellings K, et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet. 2001. 358:1851–1854.

8. Andersen B, Olesen F, Moller JK, Ostergaard L. Population-based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomized, controlled trial. J Infect Dis. 2002. 185:252–258.

9. The UK Collaborative Group for HIV and STI Surveillance. Mapping the issues. HIV and other sexually transmitted infections in the United Kingdom. 2005. London: Health Protection Agency Centre for Infections.

10. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996. 334:1362–1366.

11. Kamwendo F, Forslin L, Bodin L, Danielsson D. Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease. A 25-year study from an urban area of central Sweden. Sex Transm Dis. 1996. 23:384–391.

12. Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ. Trends in the prevalence of chlamydial infections. The impact of community-wide testing. Sex Transm Dis. 1997. 24:169–175.

13. van de Laar MJ, Morre SA. Chlamydia: a major challenge for public health. Euro Surveill. 2007. 12:E1–E2.

14. Nieuwenhuis RF, Ossewaarde JM, Gotz HM, Dees J, Thio HB, Thomeer MG, et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis. 2004. 39:996–1003.

15. Nieuwenhuis RF, Ossewaarde JM, van der Meijden WI, Neumann HA. Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin. Sex Transm Infect. 2003. 79:453–455.

16. Blank S, Schillinger JA, Harbatkin D. Lymphogranuloma venereum in the industrialised world. Lancet. 2005. 365:1607–1608.

17. Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998. 159:1224–1228.

18. Motrich RD, Maccioni M, Molina R, Tissera A, Olmedo J, Riera CM, et al. Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients. Clin Immunol. 2005. 116:149–157.

19. Mardh P, Colleen S, Holmquist B. Chlamydia in chronic prostatitis. Br Med J. 1972. 4:361.

20. Shortliffe LM, Sellers RG, Schachter J. The characterization of nonbacterial prostatitis: search for an etiology. J Urol. 1992. 148:1461–1466.

21. Bruce AW, Chadwick P, Willett WS, O'Shaughnessy M. The role of chlamydiae in genitourinary disease. J Urol. 1981. 126:625–629.

22. Bruce AW, Reid G. Prostatitis associated with Chlamydia trachomatis in 6 patients. J Urol. 1989. 142:1006–1007.

23. Poletti F, Medici MC, Alinovi A, Menozzi MG, Sacchini P, Stagni G, et al. Isolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitis. J Urol. 1985. 134:691–693.

24. Abdelatif OM, Chandler FW, McGuire BS Jr. Chlamydia trachomatis in chronic abacterial prostatitis: demonstration by colorimetric in situ hybridization. Hum Pathol. 1991. 22:41–44.

25. Shurbaji MS, Gupta PK, Myers J. Immunohistochemical demonstration of Chlamydial antigens in association with prostatitis. Mod Pathol. 1988. 1:348–351.

26. Hosseinzadeh S, Eley A, Pacey AA. Semen quality of men with asymptomatic chlamydial infection. J Androl. 2004. 25:104–109.

27. Bezold G, Politch JA, Kiviat NB, Kuypers JM, Wolff H, Anderson DJ. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril. 2007. 87:1087–1097.

28. Al-Mously N, Cross NA, Eley A, Pacey AA. Real-time polymerase chain reaction shows that density centrifugation does not always remove Chlamydia trachomatis from human semen. Fertil Steril. 2009. 92:1606–1615.

29. Gonzalez-Jimenez MA, Villanueva-Diaz CA. Epididymal stereocilia in semen of infertile men: evidence of chronic epididymitis? Andrologia. 2006. 38:26–30.

30. Pacey AA, Eley A. Chlamydia trachomatis and male fertility. Hum Fertil (Camb). 2004. 7:271–276.

31. Eley A, Pacey AA, Galdiero M, Galdiero M, Galdiero F. Can Chlamydia trachomatis directly damage your sperm? Lancet Infect Dis. 2005. 5:53–57.

32. Hosseinzadeh S, Brewis IA, Pacey AA, Moore HD, Eley A. Coincubation of human spermatozoa with Chlamydia trachomatis in vitro causes increased tyrosine phosphorylation of sperm proteins. Infect Immun. 2000. 68:4872–4876.

33. Hosseinzadeh S, Brewis IA, Eley A, Pacey AA. Co-incubation of human spermatozoa with Chlamydia trachomatis serovar E causes premature sperm death. Hum Reprod. 2001. 16:293–299.

34. Eley A, Hosseinzadeh S, Hakimi H, Geary I, Pacey AA. Apoptosis of ejaculated human sperm is induced by co-incubation with Chlamydia trachomatis lipopolysaccharide. Hum Reprod. 2005. 20:2601–2607.

35. Satta A, Stivala A, Garozzo A, Morello A, Perdichizzi A, Vicari E, et al. Experimental Chlamydia trachomatis infection causes apoptosis in human sperm. Hum Reprod. 2006. 21:134–137.

36. Gallegos G, Ramos B, Santiso R, Goyanes V, Gosalvez J, Fernandez JL. Sperm DNA fragmentation in infertile men with genitourinary infection by Chlamydia trachomatis and Mycoplasma. Fertil Steril. 2008. 90:328–334.

37. Association of Public Health Laboratories. Laboratory diagnostic testing for Chlamydia trachomatis and Neisseria gonorrhoeae [Internet]. c2010-2012. cited 2013 Jan 30. Silver Spring: Association of Public Health Laboratories;Available from: http://www.aphl.org/aphlprograms/infectious/std/documents/ctgclabguidelinesmeetingreport.pdf.

38. Hislop J, Quayyum Z, Flett G, Boachie C, Fraser C, Mowatt G. Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men. Health Technol Assess. 2010. 14:1–97.

39. Geisler WM. Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2007. 44:Suppl 3. S77–S83.

40. Akande V, Turner C, Horner P, Horne A, Pacey A;. Impact of Chlamydia trachomatis in the reproductive setting: British Fertility Society Guidelines for practice. Hum Fertil (Camb). 2010. 13:115–125.